Hairy cell leukemia 2018 Update on diagnosis, risk-stratification, and treatment

Xavier Troussard (1, 2) , Edouard Cornet (1)

1 CHU Caen
2 GPMCND - Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques

Hairy cell leukemia (HCL) and HCL-like disorders, including HCL variant (HCL-V) and splenic diffuse red pulp lymphoma (SDRPL), are a very heterogeneous group of mature lymphoid B-cell disorders, characterized by the identification of hairy cells, a specific genetic profile, a different clinical course and the need for appropriate treatment.

Domains: Life Sciences [q-bio]; Human health and pathology

Xavier Troussard, Edouard Cornet. Hairy cell leukemia 2018 Update on diagnosis, risk-stratification, and treatment. American Journal of Hematology, 2017, 92 (12), pp.1382-1390. ⟨10.1002/ajh.24936⟩. ⟨hal-02194321⟩